These stocks are moving in today's session
By Mill Chart
Last update: Mar 26, 2024
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Today's top gainers
| Ticker | Change | Comment |
|---|---|---|
| ETAO | 2.0K% | Investors witnessed a remarkable 2.0K% rise in ETAO INTERNATIONAL CO LTD's (NASDAQ:ETAO) shares, which climbed to $4.74 during Tuesday's session. In the last month the stock gained 37.59%. |
| MESO | 74.09% | MESOBLAST LTD- SPON ADR's (NASDAQ:MESO) stock price increased by 74.09% to $3.83. In the last year the stock lost 64.4%. |
| OPGN | 59.47% | With a 59.47% surge, OPGEN INC's (NASDAQ:OPGN) stock price reached $0.76 during Tuesday's session, signaling positive momentum. The company's earnings where released Yesterday. A press release (OpGen Announces Acquisition of Preferred Stock by David Lazar) was released yesterday. |
| CZOO | 58.52% | CAZOO GROUP LTD's (NYSE:CZOO) stock price displayed strong growth, advancing 58.52% and reaching $6.15 during Tuesday's session. In the last 3 months the share price dropped with 59.16%. |
| STOK | 57.0% | STOKE THERAPEUTICS INC (NASDAQ:STOK) experienced a significant 57.0% increase, reaching $10.21 during Tuesday's session. Yesterday the company had a press release: Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results. |
| DNUT | 39.52% | KRISPY KREME INC's (NASDAQ:DNUT) stock price increased by 39.52% to $17.37. A press release (McDonald’s® USA and Krispy Kreme® Announce Expanded National Partnership) was released yesterday. |
| CISS | 36.36% | C3IS INC's (NASDAQ:CISS) stock price displayed strong growth, advancing 36.36% and reaching $0.05 during Tuesday's session. Shareholders saw the stock price going 65.89% lower in the past month. |
| DERM | 30.7% | JOURNEY MEDICAL CORP (NASDAQ:DERM) rose 30.7% to $3.82 during Tuesday's after hours session. In the last month the stock lost 22.55%. |
| NUVB | 29.56% | Positive market sentiment drove NUVATION BIO INC's (NYSE:NUVB) stock price up by 29.56% to $2.92 during Tuesday's session. A press release (Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction) was released two days ago. |
| JEWL | 28.83% | Investors witnessed a remarkable 28.83% rise in ADAMAS ONE CORP's (NASDAQ:JEWL) shares, which climbed to $0.42 during Tuesday's session. Earlier today the company had a press release: Diamonds of Tomorrow: Adamas One Corp. (NASDAQ: JEWL) and the Lab-Grown Evolution. |
Our top gainers page will show you the full list.
Top losers
| Ticker | Change | Comment |
|---|---|---|
| NBSE | -51.21% | NEUBASE THERAPEUTICS INC's (NASDAQ:NBSE) shares fell 51.21% to $0.49. In the last 3 months the share price increased with 35.12%. |
| CDLX | -32.86% | CARDLYTICS INC's (NASDAQ:CDLX) stock price is declining with 32.86% to a price of $13.6. A press release (Cardlytics Announces Proposed Convertible Senior Notes Offering) was released yesterday. |
| EGOX | -26.33% | During Tuesday's session, NEXT.E.GO NV's (NASDAQ:EGOX) shares took a tumble, falling 26.33% to $0.04. The stock is trading 57.41% lower than a month ago. |
| GDS | -26.05% | There was a notable decline in GDS HOLDINGS LTD - ADR's (NASDAQ:GDS) shares, as they dropped 26.05% to $6.19 during Tuesday's session. The company's earnings where released Yesterday. A press release (GDS Appoints Jamie Khoo As CEO of GDS International) was released yesterday. |
| NCNC | -24.7% | NOCO-NOCO INC's (NASDAQ:NCNC) shares fell 24.7% to $0.25 during Tuesday's session. In the last month the share price increased with 75.95%. |
| GLUE | -22.1% | During Tuesday's session, MONTE ROSA THERAPEUTICS INC's (NASDAQ:GLUE) shares took a tumble, falling 22.1% to $6.59. Shareholders saw the stock price going 33.44% higher in the past month. |
| BLRX | -20.77% | BIOLINERX LTD-SPONS ADR's (NASDAQ:BLRX) stock price faced a 20.77% decline, reaching $1.03 during Tuesday's session. Shareholders saw the stock price going 28.57% lower is the past 6 months. |
| PNST | -20.29% | During Tuesday's session, PINSTRIPES HOLDINGS INC's (NYSE:PNST) shares took a tumble, falling 20.29% to $3.3. In the last month the stock gained 23.21%. |
| MVLA | -20.26% | MOVELLA HOLDINGS INC's (NASDAQ:MVLA) stock price is declining with 20.26% to a price of $0.09. In the last month the stock lost 55.0%. |
| WISA | -20.21% | WISA TECHNOLOGIES INC's (NASDAQ:WISA) stock price faced a 20.21% decline, reaching $0.02 during Tuesday's session. Earlier today the company had a press release: WiSA Technologies Announces Pricing of $2.3 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market. |
Our top losers page will show you the full list.
JOURNEY MEDICAL CORP
NASDAQ:DERM (4/26/2024, 7:00:00 PM)
3.4
-0.1 (-2.86%)
DERM News
SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage...
17 days ago - InvestorPlace3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.
a month ago - InvestorPlaceDERM Stock Earnings: Journey Medical Beats EPS, Beats Revenue for Q4 2023DERM stock results show that Journey Medical beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
a month ago - BusinessInsiderDERM Stock Earnings: Journey Medical Beats EPS, Beats Revenue for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Journey Medical (NASDAQ:DERM) just reported results for the fourth quarter of 2...
Company generated total revenues of $79.2 million for the full year ended December 31, 2023, a 7% increase from the $73.7 million reported in 2022 ...
Prescription Drug User Fee Act (“PDUFA”) goal date of November 4, 2024...
Company to host conference call to discuss financial results and provide a corporate update on March 21, 2024 at 4:30 p.m. ET...
SCOTTSDALE, Ariz., March 13, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical...
Clinical trial achieved all three primary objectives and subjects completed 16-week treatment with no significant safety issues Results indicate that...
4 months ago - Seeking AlphaJourney Medical submits NDA for DFD-29 for rosacea (NASDAQ:DERM)Journey Medical (FBIO) said it has submitted a New Drug Application for its rosacea treatment DFD-29. The product is being developed with Dr. Reddy's (RDY). Read more here.
If approved, DFD-29 has potential to be best-in-class and the only oral medication to address both inflammatory lesions and erythema (redness) from rosacea...
4 months ago - Seeking AlphaJourney Medical secures credit facility for up to $20M (NASDAQ:DERM)Journey Medical secures credit facility with SWK Holdings, allowing for borrowings of up to $20M to fund corporate operations and product development.
